These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39134491)
1. [Clinical analysis on the impact of pretransplant iron overload on allogeneic hematopoietic stem cell transplantation for patients with acquired severe aplastic anemia in pediatric]. Yan L; Xiong H; Long F; Chen Z; Wang Z; Yang L; Tao F; Chen Y; Song N; Wu M Zhonghua Xue Ye Xue Za Zhi; 2024 Jun; 45(6):586-590. PubMed ID: 39134491 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study. Chen X; Chen C; Zhou M; Zhang Y; Wang C; Li Y; Zhou R; Xu S; Zhou W; Deng T; Pan S; Wu L; Zhang Y; Mo W; Wang S Transplant Cell Ther; 2024 Nov; 30(11):1099.e1-1099.e10. PubMed ID: 39187160 [TBL] [Abstract][Full Text] [Related]
3. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China. Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation]. Xu Y; Zhang J; Xue SL; Miao M; Wang Y; Chen SN; Qiu HY; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):357-363. PubMed ID: 38951063 [No Abstract] [Full Text] [Related]
7. [Causes and characteristics of pre-engraftment mortality after allogeneic hematopoietic stem cell transplantation]. Liu J; Lyu M; Zhang YY; Mo XD; Sun YQ; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2024 Jun; 45(6):542-548. PubMed ID: 39134484 [No Abstract] [Full Text] [Related]
8. Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation-A Comprehensive Single Center Retrospective Analysis. Neuerburg CKF; Schmitz F; Schmitz MT; Rehnelt S; Schumacher M; Parčina M; Schmid M; Wolf D; Brossart P; Holderried TAW Transplant Cell Ther; 2024 Dec; 30(12):1195.e1-1195.e13. PubMed ID: 39299503 [TBL] [Abstract][Full Text] [Related]
9. Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation. Huang J; Pan Z; Wang L; Zhang Z; Huang J; Jiang C; Cai G; Yin T Clin Exp Med; 2024 Jan; 24(1):22. PubMed ID: 38280072 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation]. Zhang F; Wang HF; Hu GH; Suo P; Bai L; Wang Y; Zhang XH; Huang XJ; Cheng YF Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):832-837. PubMed ID: 39414606 [No Abstract] [Full Text] [Related]
11. [Prognostic analysis of 8 patients with hepatic adenoma undergoing allogeneic hematopoietic stem cell transplantation]. He Y; Xu ZL; Ma R; Liu J; Zhang YY; Lyu M; Mo XD; Yan CH; Sun YQ; Zhang XY; Wang Y; Zhang XH; Huang XJ; Xu LP Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):816-820. PubMed ID: 39414603 [No Abstract] [Full Text] [Related]
12. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification]. Wang H; Ma RZ; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):445-452. PubMed ID: 38964918 [No Abstract] [Full Text] [Related]
13. Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease. Saib I; Alahmari B; Alsadi H; Alaskar A; Hejazi A; Salama H; Al Raiza A; Saleh ASA; Ibrahim A; Bakkar M; Ghori A; Alsuhaibani A; Alharbi A; Alanazi T; Ahmed R; Shehabeddine I; Alkhraisat S; Alharbi A; Mahasneh I; Ballili M; Aljubour Z; Ahmed M; Alzahrani M Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39522720 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia]. Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596 [No Abstract] [Full Text] [Related]
16. Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Arana Ribeiro J; Alpuim Costa D; Gaio-Lima C; Guilherme Gonçalves-Nobre J; Portugal Rodrigues I; Trigo Miranda M; Pinho Vaz C; D'Espiney Amaro C; Camacho Ó Sci Rep; 2024 Oct; 14(1):24658. PubMed ID: 39428542 [TBL] [Abstract][Full Text] [Related]
17. [The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders]. Wang J; Fu HX; Zhang YY; Mo XD; Han TT; Kong J; Sun YQ; Lyu M; Han W; Chen H; Chen YY; Wang FR; Yan CH; Chen Y; Wang JZ; Wang Y; Xu LP; Huang XJ; Zhang XH Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):121-127. PubMed ID: 38604787 [No Abstract] [Full Text] [Related]
18. Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: How Do Anti-HLA Antibodies Impact?: The Impact of Anti-HLA Antibodies on Transplantation Outcomes in Thalassemia Major. Ersoy GZ; Aksoy BA; Erdem M; Karataş L; Aydoğdu S; Öner ÖB; Dikme G; Bozkurt C; Fışgın T Clin Transplant; 2024 Dec; 38(12):e70035. PubMed ID: 39601247 [TBL] [Abstract][Full Text] [Related]
19. Institutional insights into engraftment syndrome: A cohort study on allogeneic transplantation outcomes. Portich JP; Ribeiro AS; Rigoni LDC; da Rocha Silla LM; Astigarraga CC; Daudt LE; Paz AA Transpl Immunol; 2024 Dec; 87():102141. PubMed ID: 39442587 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors Associated With Increased Mortality in Pediatric Veno-Occlusive Disease Following Hematopoietic Cell Transplantation. Zaidman I; Barsoum N; Even-Or E; Daher M; Aran AA; Stepensky P; Gefen A Clin Transplant; 2024 Dec; 38(12):e70037. PubMed ID: 39601252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]